glutathione disulfide has been researched along with Cirrhosis, Liver in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Azevedo, JE; Chen, M; Ferreira, MJ; Francisco, T; Gales, L; Hang, H; Kong, X; Mao, X; Pedrosa, AG; Rodrigues, TA; Salvador, A; Wang, F; Wang, J; Yu, Y | 1 |
| Bojarska, A; Brzozowski, T; Celinski, K; Czechowska, G; Dudka, J; Korolczuk, A; Madro, A; Wojcicka, G | 1 |
| Fukushima, K; Inoue, J; Kakazu, E; Kimura, O; Kondo, Y; Ninomiya, M; Shimosegawa, T; Tamai, K; Ueno, Y; Wakui, Y | 1 |
| Castro-Sánchez, L; Chávez, E; Moreno, MG; Muriel, P; Shibayama, M; Tsutsumi, V | 1 |
| Bianchi, G; Bugianesi, E; Fabbri, A; Marchesini, G; Ronchi, M; Zoli, M | 1 |
| de Cavanagh, EM; Ferder, L; Fraga, CG; Inserra, F; Stella, I; Toblli, J | 1 |
6 other study(ies) available for glutathione disulfide and Cirrhosis, Liver
| Article | Year |
|---|---|
Topics: Acute-On-Chronic Liver Failure; Animals; Cross-Sectional Studies; Cysteine; End Stage Liver Disease; Glutathione; Glutathione Disulfide; Homeostasis; Humans; Hydrogen Peroxide; Leukocytes, Mononuclear; Liver Cirrhosis; Liver Transplantation; Mammals; Osteopontin; Oxidation-Reduction; Peroxisomes; Prognosis; Prospective Studies; Protein Disulfide Reductase (Glutathione); Proteins; Rats; Retrospective Studies; Risk Factors | 2023 |
The effect of the angiotensin II receptor, type 1 receptor antagonists, losartan and telmisartan, on thioacetamide-induced liver fibrosis in rats.
Topics: Alanine Transaminase; Alkaline Phosphatase; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Antioxidants; Aryldialkylphosphatase; Aspartate Aminotransferases; Benzimidazoles; Benzoates; Cytokines; Glutathione; Glutathione Disulfide; Liver; Liver Cirrhosis; Losartan; Male; Rats, Wistar; Telmisartan; Thioacetamide | 2016 |
Plasma L-cystine/L-glutamate imbalance increases tumor necrosis factor-alpha from CD14+ circulating monocytes in patients with advanced cirrhosis.
Topics: Adult; Aged; Aged, 80 and over; Amino Acid Transport System y+; Biological Transport; Cell Line; Cell Line, Tumor; Cells, Cultured; Cystine; Dose-Response Relationship, Drug; Female; Glutamic Acid; Glutathione; Glutathione Disulfide; Humans; Interleukin-10; Jurkat Cells; Linear Models; Lipopolysaccharide Receptors; Liver Cirrhosis; Male; Middle Aged; Monocytes; Reverse Transcriptase Polymerase Chain Reaction; Tumor Necrosis Factor-alpha | 2011 |
Sulfasalazine prevents the increase in TGF-β, COX-2, nuclear NFκB translocation and fibrosis in CCl4-induced liver cirrhosis in the rat.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Carbon Tetrachloride; Collagen; Cyclooxygenase 2; gamma-Glutamyltransferase; Glutathione; Glutathione Disulfide; Lipid Peroxidation; Liver Cirrhosis; Liver Cirrhosis, Experimental; Male; NF-kappa B; Rats; Rats, Wistar; Sulfasalazine; Transforming Growth Factor beta | 2012 |
Glutathione kinetics in normal man and in patients with liver cirrhosis.
Topics: Adult; Aged; Antidotes; Cysteine; Erythrocytes; Female; Glutathione; Glutathione Disulfide; Half-Life; Humans; Liver; Liver Cirrhosis; Male; Methionine; Middle Aged; Spectrometry, Fluorescence; Taurine | 1997 |
Enalapril attenuates oxidative stress in diabetic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enalapril; Fibrosis; Glutathione; Glutathione Disulfide; Kidney; Lipid Metabolism; Liver; Liver Cirrhosis; Male; Myocardium; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 2001 |